Suppr超能文献

玻璃体内意外注射丝裂霉素C的后果。

Consequences of inadvertent intravitreal Mitomycin C injection.

作者信息

Mirshahi Ahmad, Lashay Alireza, Mehrabi Bahar Mohammad Reza, Abrishami Mojtaba

机构信息

1Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.

2Eye Research Center, Khatam Eye Hospital, Mashhad University of Medical Sciences, Qarani Blvd., Mashhad, 9195965919 Iran.

出版信息

Int J Retina Vitreous. 2018 Feb 12;4:7. doi: 10.1186/s40942-018-0110-6. eCollection 2018.

Abstract

BACKGROUND

Mitomycin C (MMC) as an alkylating agent is miscellaneous an antineoplastic, antibiotic and ophthalmic agent. Here we aim to report a case of inadvertent intravitreal MMC injection instead of Avastin in case of diabetic macular edema.

CASE PRESENTATION

A 53 years old woman was planned to receive intravitreal Avastin injection, but accidentally, 0.05 ml of MMC 0.2% was injected. Best corrected visual acuity (BCVA) was 20/160 before injection. After 2 days, patient was referred to a tertiary referral eye center. BCVA was hand motion at presentation. Intraocular pressure was 4 mmHg. In slit lamp exams, conjunctival injection, corneal edema, Descemet fold, anterior chamber and anterior vitreous cells were presented. Pars plana vitrectomy with peripheral vitreous shaving and silicone oil tamponade was performed. Electroretinography showed undetectable responses. Ultrasound biomicroscopy showed ciliary body shortening and detachment. Optical coherent tomography showed diffuse retinal edema the day after surgery, subretinal fluid pockets in 2 weeks, and atrophy with undetectable and intertwined layers 2 months later. Gradually, like the retina, iris became atrophic and pigments were dispersed diffusely over the lens and endothelium.

CONCLUSION

MMC is showed to be severely toxic to intraocular tissues. In our case, iris and ciliary body became atrophic. Ciliary body detachment induced hypotony. Moreover, MMC induces retinal necrosis and atrophy. Visual outcome is profoundly poor.

摘要

背景

丝裂霉素C(MMC)作为一种烷化剂,是一种兼具抗肿瘤、抗生素和眼科用药特性的药物。在此,我们旨在报告一例在糖尿病性黄斑水肿治疗中误将MMC玻璃体内注射而非阿瓦斯汀注射的病例。

病例报告

一名53岁女性计划接受玻璃体内阿瓦斯汀注射,但意外注射了0.05毫升0.2%的MMC。注射前最佳矫正视力(BCVA)为20/160。2天后,患者被转诊至三级眼科转诊中心。就诊时BCVA为手动视力。眼压为4mmHg。裂隙灯检查显示结膜充血、角膜水肿、后弹力层褶皱、前房和前部玻璃体有细胞。进行了玻璃体切割联合周边玻璃体切除及硅油填充术。视网膜电图显示无反应。超声生物显微镜检查显示睫状体缩短和脱离。光学相干断层扫描显示术后第一天视网膜弥漫性水肿,2周时出现视网膜下液腔,2个月后出现萎缩且各层难以分辨并相互交织。逐渐地,与视网膜一样,虹膜也发生萎缩,色素弥漫性地散在晶状体和内皮上。

结论

MMC对眼内组织具有严重毒性。在我们的病例中,虹膜和睫状体发生萎缩。睫状体脱离导致低眼压。此外,MMC诱导视网膜坏死和萎缩。视力预后极差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eff/5808448/2e8a3f00b3c1/40942_2018_110_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验